Department of Urology, Weifang People's Hospital, Weifang, Shandong Province, China.
Department of Urology, Shouguang Hospital of Traditional Chinese Medicine, Shouguang, Shandong Province, China.
Medicine (Baltimore). 2024 Oct 25;103(43):e40167. doi: 10.1097/MD.0000000000040167.
Aggressive clear cell renal cell carcinoma (ccRCC) has a bad prognosis. We seek new ccRCC biomarkers for diagnosis and treatment. We used exoRBase and The Cancer Genome Atlas Database to compare DEmRNAs, DEmiRNAs, DElncRNAs, and DEcircRNAs in ccRCC and normal renal tissues. CircRNAs and circRNAs targeting microRNAs (miRNAs) were anticipated and taken intersections, and several databases assessed the targeted link between common miRNAs and messenger RNAs (mRNAs). The Cancer Genome Atlas database was used to create a predictive mRNA signature that was validated in E-MTAB-1980. Finally, we examined competing endogenous RNA network miRNAs and long noncoding RNAs for ccRCC predictive biomarkers using overall survival analysis. We built the first competing endogenous RNA regulation network of circRNA-lncRNA-miRNA-mRNA and found that it substantially correlates with ccRCC prognosis. We unveiled ccRCC's posttranscriptional regulation mechanism in greater detail. Our findings identified novel biomarkers for ccRCC diagnosis, therapy, and prognosis.
侵袭性肾透明细胞癌 (ccRCC) 预后不良。我们正在寻找新的 ccRCC 生物标志物用于诊断和治疗。我们使用 exoRBase 和癌症基因组图谱数据库比较 ccRCC 和正常肾组织中的差异表达的信使 RNA (DEmRNAs)、差异表达的 microRNAs (DEmiRNAs)、差异表达的长链非编码 RNA (DElncRNAs) 和差异表达的环状 RNA (DEcircRNAs)。预测环状 RNA 和靶向 microRNAs (miRNAs)的环状 RNA,取交集,并用几个数据库评估常见 miRNA 和信使 RNA (mRNA) 之间的靶向关系。使用癌症基因组图谱数据库构建了一个预测 mRNA 特征,并在 E-MTAB-1980 中进行了验证。最后,我们通过总生存分析,对竞争性内源 RNA 网络 miRNA 和长链非编码 RNA 进行 ccRCC 预测生物标志物的检验。我们构建了首个环状 RNA-lncRNA-miRNA-mRNA 的竞争性内源 RNA 调控网络,发现它与 ccRCC 的预后有很大的相关性。我们更详细地揭示了 ccRCC 的转录后调控机制。我们的研究结果为 ccRCC 的诊断、治疗和预后提供了新的生物标志物。